
第六届药物化学与新药研发国际研讨会 (MCDD 2026)
The 6th Intl Conference on Medicinal Chemistry and Drug Discovery(MCDD 2026)
会议时间:2026年7月17-19日
会议地点:bet36体育在线: · 成都
会议官网:https://www.academicx.org/MCDD/2026/
投稿邮箱:contact7@academicx.org (intelconf@163.com)
官方微信:18672346485, 3025797047
联系电话: +86 18672346485(周一到周五))
△. 大会简介
第六届药物化学与新药研发国际研讨会 (MCDD 2026) 将于2026年7月17-19日在bet36体育在线:成都举行。MCDD 2026议题涵盖动物实验,化验开发,生物标志物,生物分子,生物传感器,生物技术,化学合成,临床研究和副作用报告等。本届大会将继续遵循学术性、国际性的原则,特邀国内外相关相关领域内的学者专家前来参会,并做出精彩的报告。
△. 大会嘉宾

University of Liverpool, UK
Title: From Retina to Whole Body Insight: How AI and LLMs Are Transforming Ophthalmology

Associate Professor Abdul Nasir bin Abd Ghafar
University Malaysia Pahang Al-Sultan Abdullah, Malaysia
Title: Empowering Neurodiversity: Leveraging AI to Unlock the Potential of Students with Mental Disabilities

University of Regensburg, Medical Faculty, Regensburg, Germany
Title: Designing and Managing Intelligent and Ethical Preventive, Predictive, Personalized, Participative Precision Medicine Ecosystems

Associate Professor Le Nguyen Quoc Khanh
Taipei Medical University, China
Title: Toward Unified Multimodal Intelligence in Healthcare

Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education; School of Pharmacy, Yunnan University, China
Title: Exosome-Encapsulated Polymethoxy Ruthenium–Iron Oxide Nanoparticles for Multimodal Therapy and Imaging of Drug-Resistant Cancer

Department of Biochemistry, College of Medicine, Dubai Medical University, United Arab Emirates
Title: Ru (II) complexes a promising player: A new antitumor strategy in triple negative breast cancers

Hebei University of Technology, China
Title: Discovery of the allosteric gating mechanism of the ANO1 channel, validation of target activity and development of carrier-free nanosystems
Prof. Chang Yang
Guizhou Medical University
Title: Applications of Bletilla striata Polysaccharide in Drug Delivery Systems
△. 参会方式
1、全文参会(参会 + 全文发表 + 报告)
投递全文并参会,录用的文章发表在开源期刊上;
一篇文章的注册费含一位作者的参会费用,将安排做15-20分钟的口头报告;
2、摘要参会(参会 + 摘要 + 报告 )
投递摘要并参会,安排15-20分钟口头报告;
3、听众参会:无报告仅参会
△. 文章出版
出版物:所有被会议录用的英文稿件将会发表在国际英文开源期刊的正刊上, 更多详情请与我们联系(contact7@academicx.org)。
检索:知网学术收录
投稿须知:
1. 初版文章必须是PDF或WORD版格式,并统一通过网上投稿系统或组委会邮箱提交。终版文章必须是可编辑的WORD版格式或Latex文件包。
2. 如果您只是参会作报告,不需要发表文章,只需要将摘要提交到投稿系统。
3. 您可点击左上角Template for Manuscripts下载全文投稿模板,按照此模板准备文章。全文篇幅建议15-20页(按照模板格式,带图和参考文献),超过20页需缴纳超页费。摘要投稿需使用英文书写,无格式要求,具备标题、内容、关键词、作者信息即可,篇幅建议控制在1页以内,最长不超过2页。
4. 投稿之后5-7个工作日内您会收到审核结果,如逾期未收到邮件通知,请您尽快联系我们。
5. 可投中文稿件,文章题目、摘要,关键词需要中英双语,正文部分为中文(可联系我们索取模板文档)。参会时口头报告/海报张贴必须做英文的。
△. 大会日程(供参考)
2026年7月17日 - 大会签到(发指南、期刊、参会证、餐券等相关物资)
2026年7月18日 - 特邀演讲嘉宾报告
2026年7月19日 - 作者报告
该会议征文涉及领域包括(但不限于):
Target Identification and Validation
Chemical Biology and Probe Development
Hit Identification Strategies
Structure-Based Drug Design (SBDD)
Ligand-Based Drug Design (LBDD)
Lead Generation and Optimization
Innovative Synthetic Methodologies
Case Studies in Lead Optimization
Overcoming Medicinal Chemistry Challenges
Beyond Small Molecules
Advances in Biologics
Computational and AI-Driven Advances
Oncology and Immuno-Oncology
Infectious Diseases
Neuroscience & CNS Disorders
Cardiovascular and Metabolic Diseases
Inflammation and Autoimmune Diseases
ADME/PK Studies
Drug Delivery and Formulation Chemistry
Overcoming the Blood-Brain Barrier (BBB)
Chemical Toxicity and Safety
Pharmaceutical Analysis
Structure–activity Relationships
Target Selection
Natural Products Chemistry
Biomarker Development
Chemical Process Development and Scale-Up
Academic-Industrial Collaborations
Case Studies of Recent Drug Approvals
bet36体育在线内容可能会有差异,一切以官网为准-会议官网:https://www.academicx.org/MCDD/2026/
2、若您发现信息有误或需要信息发布,请联系:
010-50830819;邮箱:meeting@scitoday.cn.




